123 related articles for article (PubMed ID: 38547743)
1. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma.
Lu XY; Jiang J; Chen S; Qiu YJ; Wang Y; Cheng J; Xu XL; Dong Y; Wang WP
Eur J Radiol; 2024 Jun; 175():111439. PubMed ID: 38547743
[TBL] [Abstract][Full Text] [Related]
2. Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound.
Lu XY; Guo X; Zhang Q; Qiu YJ; Zuo D; Chen S; Tian XF; Zhou YH; Dong Y; Wang WP
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359506
[TBL] [Abstract][Full Text] [Related]
3. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
4. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
6. Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn's Disease.
Wang Y; Wei L; Ge WS; Duan YR; Ding WJ; Lu XY; Huang YL; Chen S; Dong Y; Du P
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611585
[TBL] [Abstract][Full Text] [Related]
7. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
8. Subtype prediction of intrahepatic cholangiocarcinoma using dynamic contrast-enhanced ultrasound.
Zhu MR; Zhao CK; Sun YK; Li XL; Yin HH; Lu D; Ye X; Hu XY; Wang X; Xia HS; Han H; Zhou BY; Xu HX; Wang LF
Insights Imaging; 2024 May; 15(1):119. PubMed ID: 38755299
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
Ainora ME; Cerrito L; Liguori A; Mignini I; De Luca A; Galasso L; Garcovich M; Riccardi L; Ponziani F; Santopaolo F; Pompili M; Gasbarrini A; Zocco MA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239893
[TBL] [Abstract][Full Text] [Related]
11. The value of dynamic contrast enhanced ultrasound (DCE-US) in monitoring treatment effect of high-intensity focused ultrasound (HIFU) in locally advanced pancreatic cancer (LAPC).
Zuo D; Feng Y; Zhang Q; Qiu YJ; Tian XF; Shi SN; Dong Y; Liu TS; Wang WP
Clin Hemorheol Microcirc; 2021; 77(3):323-333. PubMed ID: 33252067
[TBL] [Abstract][Full Text] [Related]
12. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
[TBL] [Abstract][Full Text] [Related]
13. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
15. A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Wang LF; Guan X; Shen YT; Zhou BY; Sun YK; Li XL; Yin HH; Lu D; Ye X; Hu XY; Yang DH; Xia HS; Wang X; Lu Q; Han H; Xu HX; Zhao CK;
Abdom Radiol (NY); 2024 Feb; 49(2):458-470. PubMed ID: 38225379
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound.
Wa ZC; Du T; Li XF; Xu HQ; Suo-Ang QC; Chen LD; Hu HT; Wang W; Lu MD
BMC Med Imaging; 2020 Aug; 20(1):101. PubMed ID: 32854653
[TBL] [Abstract][Full Text] [Related]
17. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
18. Quantitative perfusion analysis in pancreatic contrast enhanced ultrasound (DCE-US): a promising tool for the differentiation between autoimmune pancreatitis and pancreatic cancer.
Vitali F; Pfeifer L; Janson C; Goertz RS; Neurath MF; Strobel D; Wildner D
Z Gastroenterol; 2015 Oct; 53(10):1175-81. PubMed ID: 26480053
[TBL] [Abstract][Full Text] [Related]
19. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.
Chen LD; Xu HX; Xie XY; Lu MD; Xu ZF; Liu GJ; Liang JY; Lin MX
Br J Radiol; 2008 Nov; 81(971):881-9. PubMed ID: 18941048
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
